Sodium-glucose linked transporter 2 inhibitors (SGLT2s) and alanine aminotransferase levels (ALT) in the Associated of British Clinical Diabetologists (ABCD) audits

被引：0

作者：

Gallen, I. ^{[1
]}

Crabtree, T. S. J. ^{[2
,3
]}

Gallagher, A. ^{[4
]}

Dhatariya, K. ^{[5
]}

Bickerton, A. ^{[6
]}

Elliott, J. ^{[7
]}

Rayman, G. ^{[8
]}

Ryder, R. E. J. ^{[2
]}

机构：

[1] Royal Berkshire NHS Fdn Trust, Reading, Berks, England

[2] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England

[3] Univ Nottingham, Nottingham, England

[4] Univ Hosp Leicester NHS Trust, Leicester, Leics, England

[5] Norfolk & Norwich Univ Hosp NHS Trust, Norwich, Norfolk, England

[6] Yeovil Dist Hosp NHS Trust, Yeovil, England

[7] Sheffield Teaching Hosp NHS Trust, Sheffield, S Yorkshire, England

[8] East Suffolk & North Essex NHS Trust, Ipswich, Suffolk, England

来源：

DIABETOLOGIA | 2021年 / 64卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

424

引用

页码：218 / 218

页数：1

共 50 条

[1] Effect of Raised Alanine Transaminase (ALT) Levels on HbA1c in the Association of British Clinical Diabetologists (ABCD) Nationwide Audits of SGLT2 Inhibitors (SGLT2i)
Deshmukh, Harshal
Bickerton, Alex
Phillips, Suzanne M.
Evans, Alison
Raghavan, Rajeev P.
Sennik, Devesh K.
Rohilla, Anurita
Adamson, Karen
Yadagiri, Mahender
Gallen, Ian W.
Ryder, Robert E.
Sathyapalan, Thozhukat
DIABETES, 2020, 69
[2] Sodium-glucose link transporter-2 inhibitors in reduced renal function: cross-class comparison from the Association of British Clinical Diabetologists (ABCD) audits
Crabtree, T. S. J.
Bickerton, A.
Dhatariya, K.
Gallagher, A.
Elliott, J.
Raghavan, R.
Gallen, I. W.
Ryder, R. E. J.
DIABETOLOGIA, 2022, 65 (SUPPL 1) : S280 - S280
[3] The Effect of Semaglutide on Alanine Aminotransferase (ALT) Levels: Results from the Association of British Clinical Diabetologists (ABCD) Audit
Crabtree, Thomas S. J.
Sennik, Devesh K.
Bickerton, Alex
Barnes, Dennis
Sivappriyan, Siva
Adamson, Karen
Phillips, Suzanne M.
Evans, Alison
Larsen, Niels
Panesar, Avinash
Cull, Melissa L.
Gallen, Ian W.
Idris, Iskandar R.
Ryder, Robert E.
DIABETES, 2022, 71
[4] Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in type 1 diabetes
Dashora, Umesh
Patel, Dipesh
Gregory, Rob
Nagi, Dinesh
BRITISH JOURNAL OF DIABETES, 2018, 18 (03): : 117 - 121
[5] Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors
Wilcox, Christopher S.
HYPERTENSION, 2020, 75 (04) : 894 - 901
[6] Association of British Clinical Diabetologists (ABCD) position statement on the risk of diabetic ketoacidosis associated with the use of sodium-glucose cotransporter-2 inhibitors
Dashora, Umesh
Gallagher, Alison
Dhatariya, Ketan
Winocour, Peter
Gregory, Rob
BRITISH JOURNAL OF DIABETES, 2016, 16 (04): : 206 - +
[7] The Effect of Canagliflozin on Alanine Aminotransferase (ALT) Levels: Data from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit Programme
Crabtree, Thomas S. J.
Phillips, Suzanne M.
Evans, Alison
Sennik, Devesh K.
Rohilla, Anurita
Bickerton, Alex
Darzy, Ken H.
Winocour, Peter
Cull, Melissa L.
Strzelecka, Anna
Raghavan, Rajeev P.
Gallen, Ian W.
Yadagiri, Mahender
Ryder, Robert E.
DIABETES, 2020, 69
[8] Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors—Fighting Diabetes from a New Perspective
Theodoros P. Angelopoulos
John Doupis
Advances in Therapy, 2014, 31 : 579 - 591
[9] Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors-Fighting Diabetes from a New Perspective
Angelopoulos, Theodoros P.
Doupis, John
ADVANCES IN THERAPY, 2014, 31 (06) : 579 - 591
[10] Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)
Dashora, Umesh
Patel, Dipesh C.
Gregory, Robert
Winocour, Peter
Dhatariya, Ketan
Nagi, Dinesh
BRITISH JOURNAL OF DIABETES, 2019, 19 (01): : 66 - 72

← 1 2 3 4 5 →